肺切除术后肋间导管局部罗哌卡因镇痛的随机双盲安慰剂对照优效性研究
该随机双盲安慰剂对照优效性研究在解剖性VATS肺切除患者中评估经肋间导管持续局部给予罗哌卡因0.2%的镇痛效果,术后72小时以6-8 ml/h输注。
要点
- 经肋间导管持续局部罗哌卡因对VATS肺切除术后疼痛评分无显著改善。
- 罗哌卡因组与安慰剂组吗啡消耗量无统计学显著差异。
- 术后24小时内咳嗽时NRS评分两组分别为4.9与4.3,P=0.47。
核心结论
- 初步结果表明经手术放置的肋间导管持续局部给予罗哌卡因对术后疼痛评分或吗啡需求无正面效果。
研究设计与样本
- 样本量按疼痛数值评定量表(NRS)降低1.5分的差异计算。
主要发现
- 两组患者特征及术前疼痛评分相似。
- 术后疼痛评分及吗啡消耗量两组间无统计学显著差异。
- 术后第一个24小时咳嗽时平均NRS罗哌卡因组为4.9(SD 2.2),安慰剂组为4.3(SD 2.4),P=0.47。
- 未发现所给予罗哌卡因对术后肺功能(FEV1、PEF)有任何影响。
临床怎么用
- 该初步结果不支持将经肋间导管持续局部罗哌卡因作为VATS肺切除术后镇痛的标准治疗。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Postoperative pain remains a burden for patients after minimally invasive anatomic lung resection. Current guidelines recommend the intraoperative placement of intercostal catheters to promote faster recovery. This trial aimed to determine the analgesic efficacy of continuous loco-regional ropivacaine application via intercostal catheter and establish this method as a possible standard of care. METHODS: Between December 2021 and October 2023, patients were randomly assigned to receive ropivacaine 0.2% or a placebo through an intercostal catheter with a flow rate of 6-8 ml/h for 72 h after surgery. Patients were undergoing anatomic VATS lung resection under general anaesthesia for confirmed or suspected stage I lung cancer (UICC, 8th edition). The sample size was calculated to assess a difference in numerical rating scale associated with pain reduction of 1.5 points. RESULTS: Fourteen patients were included in the ropivacaine group, whereas the placebo group comprised 18 participants. Patient characteristics and preoperative pain scores were similar in both groups. There was no statistically significant difference in postoperative pain scores and morphine consumption between the 2 groups. The mean numerical rating scale when coughing during the first 24 h postoperatively was 4.9 (SD: 2.2) in the ropivacaine group and 4.3 (SD: 2.4); P = 0.47 in the placebo group. We were unable to determine any effect of administered ropivacaine on the postoperative pulmonary function (FEV1, PEF). CONCLUSIONS: Our preliminary results suggest that continuous loco-regional ropivacaine administration via surgically placed intercostal catheter has no positive effect on postoperative pain scores or morphine requirements. CLINICAL REGISTRATION NUMBER: NCT04939545.
引用
- Hojski A, Krämer M, Gecas P, et al. The efficacy of loco-regional ropivacaine analgesia via intercostal catheters after lung resection: a randomized, double-blind, placebo-controlled, superiority study. Eur J Cardiothorac Surg. 2024. PMID: 39352775. doi:10.1093/ejcts/ezae342
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。